title: What is CRISPR/Cas9?
authors.affiliation: HYMS Centre for Education Development (CED), Hull York Medical School, University of York, York, UK.
authors.forename: Melody
authors.initials: M
authors.lastname: Redman
authors.affiliation: Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.
authors.forename: Andrew
authors.initials: A
authors.lastname: King
authors.affiliation: Department of Haematology, Oxford University NHS Foundation Trust, Churchill Hospital, Oxford, UK.
authors.forename: Caroline
authors.initials: C
authors.lastname: Watson
authors.affiliation: Academic Unit of Child Health, Sheffield Children's Hospital, Sheffield, UK.
authors.forename: David
authors.initials: D
authors.lastname: King
mesh_terms: D000293:Adolescent; D064130:CRISPR-Associated Proteins / Q000235:genetics*; D064113:CRISPR-Cas Systems / Q000235:genetics* / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D064112:Clustered Regularly Interspaced Short Palindromic Repeats / Q000276:immunology*; D019468:Disease Management; D005260:Female; D020868:Gene Silencing / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010372:Pediatrics / Q000379:methods*; D055815:Young Adult
chemical_list: D064130:CRISPR-Associated Proteins
keywords: CRISPR/cas9; children; gene editing; genome engineering